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Abstract
Background The findings form studies on the relationship between vitamin D and type 2 diabetes were inconsistent.
Objectives To elucidate the association between vitamin D consumption and type 2 diabetes risk by conducting a meta-
analysis.
Methods We conducted a systematic literature search to identify prospective cohort studies of  vitamin D intake and type 2
diabetes risk prior to November 2012. Eligible studies were retrieved via both computer searches and manual review of
references. The summary risk estimates were calculated based on the highest versus the lowest categories.
Results Meta-analysis of 4 prospective cohort studies involving 187, 592 participants and 9, 456 incident cases showed an
absence of significant association between total vitamin D intake and type 2 diabetes risk. The combined RR was 0.93 (95%
CI: 0.85–1.01). The associations were similar for subgroup analyses, a combined RR respectively was 0.94 (95% CI: 0.77-
1.08), 0.91 (95% CI: 0.77-1.08), 0.93 (95% CI: 0.84-1.02), and 0.92 (95% CI: 0.84–1.01) for the intake of  dietary vitamin D,
supplemental vitamin D, total vitamin D in USA and total vitamin D for women only.
Conclusions Our results support that there was no association between vitamin D intake and type 2 diabetes.
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Diabetes mellitus is a group of metabolic diseases
in which a person is characterized by high blood
sugar producing the classical symptoms of frequent
urination, increased thirst and increased hunger1. Type
2 diabetes is caused by insulin resistance, a disease in
which cells do not respond to the insulin properly,
sometimes coupled with relatively insulin deficiency2.
Type 2 diabetes mellitus is one of  the 10 most
prevalent diagnosed diseases in a representative US
population of men older than 50 years of age, with
a further increase of average 7 million people affected
by diabetes each year3. There will be approximately
438 million developing diabetes by 2030, accounting
for 4.4% of all age groups worldwide4. Smoking,
ageing, obesity and physical inactivity are the well-
known risk factors for diabetes 5. Currently, feasible
preventive measures of this disease remain limited.
Vitamin D is a group of  fat-soluble prohormones
enhancing the absorption and metabolism of calcium
and phosphorous. A large number of  evidence
indicated that vitamin D might have important roles
in cardiovascular disease, autoimmune disorders,
cancers and type 2 diabetes6, 7. In the past few years,
the roles of  vitamin D in the etiology of  type 2
diabetes have received considerable attentions in
research fields. There is mounting evidence from
cross-sectional studies8, 9, or even stronger study
designs such as randomized controlled trial studies
(RCTs)6. As we know, a cohort study is undertaken
to support the existence of association between
suspected cause and disease achieving a more and
long-term result, while a RCT study often needs to
be end at the scheduled termination time, and the
follow-up time is often shorter. However, findings
from prospective cohort studies on the association
between vitamin D and Type 2 diabetes are
inconsistent10-13. To the best of  our knowledge, there
is no a comprehensive assessment of the relation
between vitamin D intakes and type 2 diabetes risks
by summarizing the prospective cohort studies.
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In response, we conducted this first meta-
analysis by pooling together the results from all
published prospective cohort studies. Our purpose
was to examine the potential association between
vitamin D intake and risk of  type 2 diabetes.
Methods
Literature Search
We attempted to conduct this study in line with the
Meta-analysis of  Observational Studies in
Epidemiology guidelines for meta-analyses of
observational studies14. Our literature search was
conducted with a systematic literature search at
November 2012, which included MEDLINE,
PubMed, Science Direct, Springer link, EMBASE
and Chinese National Knowledge Infrastructure
(CNKI). The keywords of our search were as
following:
#1. (vitamin D) OR (vit D) OR VD OR
ergocalciferol*
#2. (Type 2 diabetes) OR diabetes mellitus OR
T2DM OR (impaired glucose tolerance) OR
(impaired fasting glucose) OR (abnormal glucose
metabolism)
#3. #1 and #2
The search was limited on human studies, without
any other restriction. References listed in the searched
papers were used for additional screening of relevant
data. This process was performed by two
investigators independently. Any disagreement among
the investigators was resolved by consensus. When
necessary, we contacted the authors of  original studies
for additional data. Furthermore, we have also
searched the Cochrane Online, the Clinical Trials
Online and contacted the organization of Chinese
medical doctorate dissertation database to acquire
related unpublished reports.
Inclusion and exclusion criteria
The study can be included as a candidate if it met
the following criteria: 1) It is an original prospective
cohort study on human subject which have
mentioned the association between vitamin D and
type 2 diabetes; 2) The primary outcome clearly was
defined as type 2 diabetes; 3) Only the most recent
study would be included if multiple publications were
on the same population study or the same results
were published in different journals; 4) The studies
provided relative risk (RR) and its 95% confidence
interval (95% CI), or studies had raw data available
in the paper for calculating these parameters; 5) The
RR and the corresponding 95% CI extracted from
the literature were compared to obtain the highest
and the lowest amount of vitamin D intake; 6) In
the included studies, the participants should generally
be healthy people in the researcher’s region; 7) As
we know, the association between type 2 diabetes
and vitamin D intake was a slow-progressed effect,
a short term follow-up may not expose such an
effect. Based on the original articles, we therefore
have defined that the follow-up period of cohort
participants should not be short than five years. The
exclusion criteria were: duplicates data, no usable data
reported and Communication letters, reviews,
editorials, abstracts and conference proceedings
published in non-peer-reviewed journals15 .
Data extraction
Data extracted from the selected papers included
the following information: the name of  the first
author, publication year, gender, location of the
study, duration of  follow-up, sample size, the number
of type 2 diabetes cases, the consumption level of
vitamin D, adjustments and risk estimates with 95%
CI. When more than one data set presented in one
study, the one adjusted by more potential
confounders was used to meet with the optimal
control of  confounding factors. All data was
extracted by two reviewers independently according
to the pre-specified selection criteria. Disagreement
was resolved by discussion with co-authors by
reviewing the full text.
The quality of each study was completed by
the other two investigators independently. All the
evaluated work was processed by reporting
following crucial components of eligible studies: a
clearly stated aim, clear examination of exposure and
outcome, clear definition of participant
characteristics, study duration, sufficient duration of
follow-up, person-years of  follow-up, no selective
loss during follow-up and control for potential
confounding factors. If  a study did not clearly
provide one of  these key points information, we
did not consider that it had been performed, but it’s
probably underestimated the reported characteristics.
Statistical analysis
The combined risk estimates were based on
comparisons of the highest intake category with the
lowest intake category (including persons who have
no consumption of vitamin D). Between-studies
heterogeneity was measured using the Q statistic.
P<0.10 was regarded as significantly heterogeneous
and random effects models were used for analyses
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estimating the pooled RR, 95% confidence intervals,
and corresponding p-values for heterogeneity,
otherwise, fixed effects models were used16. I2 statistic
was also applied to measure the percentage of the
total variation across studies caused by heterogeneity
17, 18. Furthermore, forest plots were also examined
to assess the relationship between vitamin D intake
and type 2-diabetes. Subgroup analyses were
conducted on the basis of geographical region
(USA), gender (women), dietary vitamin D intake
and two on supplemental vitamin D intake.
To investigate whether a single study has an effect
on the overall risk estimate, we conducted a
sensitivity analysis by excluding one study in each turn.
In addition, we applied the Begg adjusted rank
correlation test and the Egger’s regression asymmetry
test to assess the possible bias captured by the funnel
plot19, 20. It should be noted both tests have low
power to detect the potential biases; especially the
numbers of studies are very limited. Therefore, we
set p = 0.1 as our statistical penalty in these two
tests. P<0.1 indicated possible publication bias16 .
All statistical analyses were using the commands in
the Stata statistical software package (version, 11.0,
Stata Corporation, College Station, TX, USA). All
statistical tests were two sided.
Results
We have retrieved 1435 articles initially, 1297 papers
were excluded after firstly screening the paper type
or subjects. 96 relative papers were exclusion after
reading the titles and abstracts. While, the other 17
studies were excluded, because the doses of vitamin
D could not be summarized in the highest versus
lowest category due to the limited data in the original
studies. Therefore, 25 articles were remained. Of
the remaining 25 studies, 14 papers reported results
without enough information (e.g.: raw data and p
value) to estimate the effect sizes and their CIs. The
other 7 studies were excluded based on the following
reasons: The results were only presented with median
and ranges. Moreover, there had not any adjusted
or unadjusted odds ratio or risk ratio that could be
summarized for meta-analysis. In addition, as is
known to all, a fixed cycle is very important in a
follow-up study. If  we cannot find any fixed follow-
up cycle definitions in some original studies, we
considered that these data may be unbelievable, and
these studies should not be included. Finally, we
identified a total of four publications with
prospective cohort studies on vitamin D intake and
the risk of type 2 diabetes according to our above
mentioned criteria. The articles selection flow chat
was presented in figure 1.
Figure 1:  The flow chart of  study selection
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They were involving 187, 592 participants and 9,
456 incident cases. The number of  cases diagnosed
in the original studies ranged from 1, 114 to 4, 843,
and the number of participants ranged from 10,
066 to 83,779. The identification of diabetes was
mainly based on self-reports of physician diagnosis,
but the majority of  cases were confirmed in
validation studies. Participants in the study reported
by Kirii et al10. were divided to men and women
individually for observation and analysis. Thus, it was
considered two studies when the observed items
were pooled. In other words, there were four papers
with five data sets in our meta-analysis. The
characteristics of the included studies are presented
in table 1. The four prospective cohort studies were
published between 2000 and 2012.
Of the included studies, three studies were
conducted in the United States11-13 and the other one
in Japan 10. The length of follow-up period ranged
from 5 to 20 years. Only one study involved men
and women 10, the remaining three studies consisted
of women only11-13. Of the studies, four reported
results on total vitamin D intake, two on dietary
vitamin D intake12, 13 and two on supplemental
vitamin D intake12, 13. Despite of the different
number of food items in the food frequency
questionnaires (FFQs) across studies, most studies
used validated FFQs to define dietary information
pertaining to vitamin D products consumption. All
the included studies considered the lowest or no
consumption of vitamin D as the reference.
Although the confounding factors varied across
studies, the major adjusted confounders in our
included studies included the most essential
confounders such as age, BMI, smoking and family
history of  diabetes.
Figure 2 revealed that the combined results
of all studies for the highest versus the lowest
category of total vitamin D intake. Of these selected
studies, only one study found a statistically significant
inverse association between total vitamin D intake
and type 2 diabetes risks. The other studies reported
no significant association between the two. The
combined RR of  Type 2 diabetes was 0.93 (95% CI
0.85–1.01) (10-13), comparing the highest with the
lowest category of total vitamin D intake. No
heterogeneity was detected across studies (P-value
for heterogeneity =0.958, I2=0 %; figure 1). We did
not conduct the dose-response analysis of studies
on vitamin D intake because the eligible studies did
not provide sufficient information on the category
data of vitamin D intake
To investigate the robustness of  our findings, we
conducted the sensitivity analyses by omitting one
study at each turn and calculating the combined RR
for the remaining studies yielded consistent results,
with a narrow range from 0.90 (95% CI, 0.81–1.61)
to 0.92 (95% CI, 0.79–1.64). Thus, we did not find
that any single study substantially influence the
combined risk estimate. In addition, there was no
evidence of publication bias with regard to
consumption of vitamin D in relation to risk of
Type 2 diabetes, as indicated by a P-value of  0.462
by Begg rank correlation test (figure 2) and a P-
value of  0.320 by Egger linear regression test.
When the studies were stratiûed by geographical
region, no significant association was observed in
USA (RR = 0.93, 95% CI: 0.84-1.02, p-value for
heterogeneity = 0.804, I2 = 0 %) (11-13). In the
subgroup analysis for women, the summary RR was
0.92 (95% CI 0.84–1.01) (10-13). To be noted, there
was no variability across the studies included women
only (p-value for heterogeneity = 0.902, I2 = 0.0 %).
Summary associations were similar between studies
on dietary vitamin D intake (RR = 0.94, 95% CI:
0.82-1.08; p-value for heterogeneity = 0.584, I2 =11.2
%) (12-13) and studies on supplemental vitamin D
intake (RR = 0.91, 95% CI: 0.77-1.08; p-value for
heterogeneity = 0.142, I2 =53.6 %) (12-13).
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Figure 2: Meta-analysis of vitamin D intake and type 2 diabetes (the highest versus the lowest
category).
The size of the square is proportional to the percent weight of each study in the meta-analysis; the
horizontal lines represent 95% CI. Studies are ordered by the year of  publication. CI: confidence interval;
ES: effect size.














Figure 3: Begger plot for the assessment of potential publication bias for vitamin D intake and type
2 diabetes. Var 2: relative risk
Discussion
It is well-known that the major function of vitamin
D is to maintain calcium and phosphorus
homeostasis and promote bone mineralization6.
Moreover, Vitamin D may have a beneficial effect
on insulin action directly via stimulating the
expression of insulin receptor resulting in enhancing
insulin responsiveness for glucose transport, or
indirectly through its role in regulating extracellular
calcium and ensuring normal calcium influx6, 21. In
experimental studies, vitamin D has been
demonstrated to improve pancreatic beta cell
function and peripheral insulin sensitivity22, 23.
However, in humans, findings on the association
between vitamin D intake and the risk of type 2
diabetes from prospective studies are limited and
inconsistent10-13.
To the best of  our knowledge, this is the first
meta-analysis of cohort studies on the potential
relationship between vitamin D intake and type 2
diabetes risk. Our present study is a meta-analysis
based on the epidemiological studies which included
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large-scale and long-term follow-up results. As we
know, a cohort study is undertaken to support the
existence of association between suspected cause and
disease. Prospective cohort study can not be
interfered by investigators, and it is more suitable
for long-term follow-up and owns high strength
evidence. Whereas, RCT often needs to be end at
the scheduled termination time, and the follow-up
time is often shorter. On the other hand, a well-
designed cohort study always can minimize the
interference or potential confounding factors of the
participants through the corrected multivariable
analyses. While these function cannot be conducted
in a RCT study. In addition, there were obvious
interventions on whether participants accepted
vitamin D in RCT studies, while the researchers did
not interfere with participants in cohort studies, this
is well conformed with the actual situation than RCT.
Here, we pooled four prospective cohort
studies involving 187, 592 participants and 9, 456
incident cases to get a more stable and creditable
result. The results suggested no significant overall
association between consumption of vitamin D and
type 2 diabetes incidence. Furthermore, among the
subgroup analyses based on women, USA continent,
dietary vitamin D intake and supplemental vitamin
D intake, no significant associations were observed.
To be noted, no substantial heterogeneity was
detected in those studies included in our present
analysis. On the basis of  Egger’s and Begg’s tests,
we have shown an absence of publication bias in
these meta-analyses. In addition, sensitivity analyses
showed none of the studies considerably affected
the summary associations between vitamin D intake
and the risk of  type 2 diabetes.
Our results compare favorably with most of
studies included in our analysis, in which they
reported that subjects consuming vitamin D were
not associated with type 2 diabetes risk. We did not
perform the dose-response analysis of  vitamin D
intake for two reasons. On one hand, our findings
did not show any relationship with risk of type 2
diabetes in our analysis. On the other hand, the four
eligible prospective cohort studies did not provide
sufficient information for a dose-response analysis
on the category data of vitamin D intake, number
of cases, person-years, and logarithm of RR and its
corresponding standard error.
The publication bias is a major concern in a
meta-analysis. Although we do not have enough
statistical power to formally test for publication bias,
there was no evidence for the smaller cohorts to
overestimate effect estimates compared with the
larger studies. In our analysis, no evidence of
publication bias was observed by setting the penalty
as p value less than 0.1, though the tests of bias have
low statistical power. More importantly, the
associations between consumption of vitamin D and
risk of type 2 diabetes appeared to be consistent
across most studies. Thereof, the likelihood that these
findings are largely a result of selective publication
seems to be minimal. However, a potential bias could
not be excluded completely.
We have several important strengths in the
present analysis. This is the first systematic
epidemiologic assessment from prospective cohort
studies to investigate the relationship between vitamin
D intake and type 2 diabetes. Because individual study
has low statistical power, our meta-analysis of four
large prospective cohort studies involving enlarged
sample size enhancing the statistical power to detect
more stable association and provide more reliable
estimation. The studies included in our meta-analysis
were prospective cohort studies with a large sample
size and long-term follow-up periods, which
increased the statistical power to quantitatively assess
the overall associations of vitamin D intake and
incidence of  type 2 diabetes. Furthermore, the
prospective study designs could minimize selection
bias and recall bias24. Moreover, the results were
further analyzed based on the subgroups and yielded
a similar conclusion, and no evidence of
heterogeneity in our analyses probably indicated the
robustness of  our findings. Additionally, the included
original studies reported the dietary intake levels of
vitamin D and supplemented vitamin D, whereas,
due to the unpooled data, our review mentioned
the dietary intake levels of  calcium and vitamin D.
Several potential limitations need to be taken
into account in our study when considering its
contributions. First, residual confounders always raise
a major concern in the epidemiology studies.
Although a wide range of potential confounding
factors, including demographic and lifestyle factors
were performed adjustment in original studies,
whereas dietary factors were not sufficiently
considered 25. We could not exclude the possibility
that the unmeasured or unknown dietary factor may
contribute to the results not entirely accurate. Second,
the primary studies reported consumption of vitamin
D by different category which might cause random
misclassifications. However, we reported the
summary relative risk estimates based on the highest
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vitamin D intake compared with the lowest intake
categories which possibly reduce the bias. Third, the
strength of the association may have been weakened
by possible misclassification bias. Misclassification of
vitamin D intake by using the method of self-
administered questionnaires is inevitable. Moreover,
because the confirmations of  type 2 diabetes in the
original studies were based on self-reports,
misclassification of type 2 diabetes cases is also likely
to occur. Additionally, our results were based on only
four studies included in this meta-analysis. The pooled
risk estimate may be affected by individual studies.
However, our sensitivity test showed the findings
were consistent, which indicated a somewhat high
degree of  robustness of  our findings. At last, due to
the unmagable data or other reasons above
mentioned, we have excluded several potential related
studies and this effect may induce potential selection
bias on our analysis. Therefore, more large-scale and
high quality studies are warranted to enhance our
results.
Conclusion
Our meta-analysis of all relevant prospective cohort
studies showed an absence of significant association
between vitamin D intake and type 2 diabetes risk.
Further studies are required to better confirm the
findings.
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